Patoulias, D., & Avranas, K. (2018). Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: From pathophysiology to clinical practice. Cardiovascular & hematological disorders, drug targets, 18, . https://doi.org/10.2174/1871529X18666180206123149
Chicago-Zitierstil (17. Ausg.)Patoulias, Dimitrios, und Konstantinos Avranas. "Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: From Pathophysiology to Clinical Practice." Cardiovascular & Hematological Disorders, Drug Targets 18 (2018). https://doi.org/10.2174/1871529X18666180206123149.
MLA-Zitierstil (9. Ausg.)Patoulias, Dimitrios, und Konstantinos Avranas. "Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: From Pathophysiology to Clinical Practice." Cardiovascular & Hematological Disorders, Drug Targets, vol. 18, 2018, https://doi.org/10.2174/1871529X18666180206123149.